Category Archives: Pharmaceutical Expert

JeanMarie Guenot Builds Another Success

Very rarely within a lifetime will the average person lead a company to financial and critical success at For most, the idea of even starting a company let alone taken on the multi-million dollar responsibility of ensuring shareholders interests are protected is beyond the realm of rational thought. Though for a few intrepid and intelligent individuals, leading a business into the black and further innovation is not only a singular moment but a daily occurrence.

Such is the case with Amphivena Therapeutic’s CEO and Founder, Jeanmarie Guenot. The doctor, pharmaceutical expert, and CEO has built her career upon leading companies forward into the future with a focus on business strategy and well-crafted research and development.

JeanMarie Guenot and the Success of Amphivena Therapeutic

JeanMarie Guenot’s latest entry into her storied career is filled not only with the success of an adept business woman but also with that of a dedicated medical practitioner. Together with the talented team over at Amphivena Therapeutic, JeanMarie Guenot has led the company to some rather groundbreaking discoveries within the field of cancer research. The work that Guenot’s team has accomplished has been mentioned in several medical publications for its revolutionary way of tackling the signs of cancer that are often found in a patient’s blood.

Creating A Cancer-Free Tomorrow

The devastation that is wrought upon those unfortunate enough to be diagnosed with cancer has caused many researchers to dedicate their lives to finding a way to stopping the deadly disease. Now the work of Amphivena Therapeutic is bringing that dream a bit closer to reality. The groundbreaking research and work performed at their facilities has found a way to lessen the suffering of those afflicted by blood-borne cancers.

If you would like to learn more about the breakthroughs taking place at Amphivena Therapeutic please visit their website for more information.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies